Subtopic Deep Dive
Arachidonic Acid Cytochrome P450 Pathways Regulation
Research Guide
What is Arachidonic Acid Cytochrome P450 Pathways Regulation?
Arachidonic acid cytochrome P450 pathways regulation involves transcriptional control by Nrf2, PPAR, and hypoxia-inducible factors on CYP enzyme expression, alongside pharmacokinetic drug interactions altering eicosanoid profiles in vascular homeostasis.
Cytochrome P450 enzymes metabolize arachidonic acid to vasoactive eicosanoids like epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acids (HETEs). Regulation occurs via transcription factors such as PPAR and Nrf2, impacting hypertension pharmacology. Over 10 papers from 2001-2021, including Fleming (2001, 382 citations) and Wang et al. (2021, 1243 citations), detail these mechanisms.
Why It Matters
Insights into CYP regulation predict drug responses in hypertension by modulating eicosanoid profiles that control vascular tone (Fleming, 2001). Pharmacokinetic interactions with CYP inhibitors inform enzyme-targeted therapies for cardiovascular diseases (Sonnweber et al., 2018). These pathways link lipid metabolism to inflammation resolution, guiding interventions in metabolic disorders (Panigrahy et al., 2010).
Key Research Challenges
Transcriptional Regulation Complexity
Nrf2, PPAR, and HIFs dynamically control CYP expression, but their interplay in hypertension remains unclear. Fleming (2001) highlights vascular CYP roles, yet context-specific activation needs mapping. Over 380 citations underscore unresolved regulatory networks.
Drug-Eicosanoid Interactions
Pharmacokinetic drugs alter CYP-mediated arachidonic acid metabolism, complicating eicosanoid profiles. Wang et al. (2021) review therapeutic targets, but predicting clinical outcomes requires better models. Sonnweber et al. (2018) note links to metabolic diseases.
Oxylipin Quantification Variability
LC-MS/MS profiling of CYP-derived oxylipins varies across tissues and conditions. Strassburg et al. (2012, 236 citations) apply methods in cardiac surgery, revealing inconsistencies. Standardization challenges persist for hypertension studies.
Essential Papers
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Bei Wang, Lujin Wu, Jing Chen et al. · 2021 · Signal Transduction and Targeted Therapy · 1.2K citations
Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA
Simon C. Dyall · 2015 · Frontiers in Aging Neuroscience · 869 citations
Omega-3 polyunsaturated fatty acids (PUFAs) exhibit neuroprotective properties and represent a potential treatment for a variety of neurodegenerative and neurological disorders. However, traditiona...
Significance of long chain polyunsaturated fatty acids in human health
Rafael Zárate, Nabil el Jaber-Vazdekis, Noemı́ Tejera et al. · 2017 · Clinical and Translational Medicine · 534 citations
Abstract In the last decades, the development of new technologies applied to lipidomics has revitalized the analysis of lipid profile alterations and the understanding of the underlying molecular m...
Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases
Thomas Sonnweber, Alex Pizzini, Manfred Nairz et al. · 2018 · International Journal of Molecular Sciences · 420 citations
Lipid and immune pathways are crucial in the pathophysiology of metabolic and cardiovascular disease. Arachidonic acid (AA) and its derivatives link nutrient metabolism to immunity and inflammation...
Cytochrome P450 and Vascular Homeostasis
Ingrid Fleming · 2001 · Circulation Research · 382 citations
Since the initial reports that renal cytochrome P450 (CYP) enzymes can metabolize arachidonic acid to substances which affect arterial tone, it has become increasingly clear that CYP enzymes expres...
Cardioprotective mechanism of omega-3 polyunsaturated fatty acids
Jin Endo, Makoto Arita · 2015 · Journal of Cardiology · 352 citations
The differential effects of EPA and DHA on cardiovascular risk factors
S Cottin, T. A. B. Sanders, Wendy L. Hall · 2011 · Proceedings of The Nutrition Society · 243 citations
Compelling evidence exists for the cardioprotective benefits resulting from consumption of fatty acids from fish oils, EPA (20:5 n -3) and DHA (22:6 n -3). EPA and DHA alter membrane fluidity, inte...
Reading Guide
Foundational Papers
Start with Fleming (2001, 382 citations) for core vascular CYP-arachidonic acid roles; follow Cottin et al. (2011, 243 citations) for PPAR effects on EPA/DHA cardiovascular factors.
Recent Advances
Study Wang et al. (2021, 1243 citations) for metabolism pathways and targets; Sonnweber et al. (2018, 420 citations) for AA metabolites in diseases.
Core Methods
LC-MS/MS for oxylipin profiling (Strassburg et al., 2012); transcription factor assays for Nrf2/PPAR; inhibitor studies for drug interactions (Panigrahy et al., 2010).
How PapersFlow Helps You Research Arachidonic Acid Cytochrome P450 Pathways Regulation
Discover & Search
Research Agent uses searchPapers and citationGraph on 'arachidonic acid CYP regulation Nrf2 PPAR' to map 50+ papers, starting from Fleming (2001, 382 citations) as central node, revealing connections to Wang et al. (2021). exaSearch uncovers hypoxia-inducible factor interactions; findSimilarPapers expands to related vascular homeostasis works.
Analyze & Verify
Analysis Agent employs readPaperContent on Fleming (2001) to extract CYP-epoxygenase details, then verifyResponse with CoVe checks claims against Sonnweber et al. (2018). runPythonAnalysis processes oxylipin LC-MS/MS data from Strassburg et al. (2012) for statistical verification; GRADE grading scores evidence strength for transcriptional regulation claims.
Synthesize & Write
Synthesis Agent detects gaps in Nrf2-CYP links via gap detection, flags contradictions between PPAR effects in Cottin et al. (2011) and Panigrahy et al. (2010). Writing Agent uses latexEditText, latexSyncCitations for pathway diagrams, and latexCompile to generate publication-ready reviews; exportMermaid visualizes regulation networks.
Use Cases
"Analyze oxylipin profiles from CYP pathways in hypertension patient data"
Research Agent → searchPapers('CYP arachidonic oxylipins hypertension') → Analysis Agent → runPythonAnalysis(pandas on Strassburg et al. 2012 LC-MS/MS data) → matplotlib plots of EET/HETE ratios for researcher.
"Draft review on PPAR regulation of arachidonic CYP in vascular homeostasis"
Synthesis Agent → gap detection on Fleming 2001 + Cottin 2011 → Writing Agent → latexEditText(draft sections) → latexSyncCitations → latexCompile → PDF manuscript with synced references for researcher.
"Find GitHub code for simulating CYP eicosanoid metabolism"
Research Agent → paperExtractUrls(Wang et al. 2021) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified simulation scripts with NumPy for eicosanoid kinetics for researcher.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(100 papers on CYP regulation) → citationGraph → GRADE all claims → structured report on Nrf2/PPAR roles. DeepScan applies 7-step analysis with CoVe checkpoints on Fleming (2001) abstracts for vascular eicosanoids. Theorizer generates hypotheses on drug-CYP interactions from Panigrahy et al. (2010) and Sonnweber et al. (2018).
Frequently Asked Questions
What defines arachidonic acid cytochrome P450 pathways regulation?
It encompasses transcriptional control by Nrf2, PPAR, and HIFs on CYP enzymes metabolizing arachidonic acid to eicosanoids, plus drug interactions altering profiles (Fleming, 2001).
What are key methods for studying these pathways?
LC-MS/MS quantifies oxylipins (Strassburg et al., 2012); reporter assays assess Nrf2/PPAR activity; inhibitors test pharmacokinetic effects (Wang et al., 2021).
What are pivotal papers?
Fleming (2001, 382 citations) establishes vascular CYP homeostasis; Wang et al. (2021, 1243 citations) reviews metabolism targets; Sonnweber et al. (2018, 420 citations) links to cardiovascular diseases.
What open problems exist?
Unresolved issues include tissue-specific Nrf2-HIF crosstalk, predicting drug-eicosanoid interactions in hypertension, and standardizing oxylipin profiling across models.
Research Eicosanoids and Hypertension Pharmacology with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Arachidonic Acid Cytochrome P450 Pathways Regulation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers